Clinical Trials Directory

Trials / Unknown

UnknownNCT05836311

Single Perclose Escalation Technique for Vascular Closure in TAVR

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study examines in the safety and efficacy of using a single Perclose escalation technique (SPET) using a single Perclose Proglide device to preclose and the need for a rescue device based on a control angiography at the end of the procedure, with a 6F femoral sheath.

Detailed description

Percutaneous femoral access is the preferred access route for transcatheter aortic valve replacement (TAVR). The majority of experienced TAVR centers use two 6F Perclose ProGlide™ devices to close the primary vascular access site, deployed prior to upsizing sheath size with closure completed at the end of the case (the double "preclose" approach). A strategy of utilizing a single Perclose device to preclose may have advantages including fewer complications, complexity, and cost, but the safety of this is unknown. This study examines in the safety and efficacy of using a single Perclose escalation technique (SPET) using a single Perclose Proglide device to preclose and the need for a rescue device based on a control angiography at the end of the procedure, with a 6F femoral sheath. The use of Femoseal in mild bleedings, and a second Perclose Proglide for moderate to severe bleedings. Compare this SPET technique with double Preclose technique, with two historical cohorts of patients. One cohort of patients with SPET technique since started this technique, and a second cohort with double perclose technique prior to starting SPET technique.

Conditions

Interventions

TypeNameDescription
DEVICEOne Perclose Proglide SutureOne Perclose Proglide Suture
DEVICETwo Perclose Proglide SutureOne Perclose Proglide Suture

Timeline

Start date
2023-07-19
Primary completion
2025-02-19
Completion
2025-02-19
First posted
2023-05-01
Last updated
2023-05-03

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05836311. Inclusion in this directory is not an endorsement.